Glioblastoma

Questions discussed in this category

What factors do you take into account when deciding the length of adjuvant temozolamide in GBM?

For a patient with large volume glioblastoma, what do you do if they are found to have a subdural infection in the middle of chemoRT requiring repeat surgery?

Would the extent of initial resection change your management in any way?

1 Answer available

How do you balance short-term efficacy against increased low-grade toxicity and quality-of-life considerations for higher single-fraction regimens in recurrent glioma patients?

This question is part of our collaboration with ASTRO 2025 to highlight impactful trial data from this year's meeting. This question is inspired by th...

1 Answer available

How do you counsel glioblastoma multiforme patients on which types of clinical trials to pursue?

1 Answer available

How would you approach treatment for a glioblastoma from a radiation standpoint that was initially thought to be a metastases and therefore treated with multiple courses of SRS over the past few years?

1 Answer available

Papers discussed in this category

Journal of neuro-oncology, 2024 Jan 23

The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.

Acta neurochirurgica, 2021 Apr 02

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review.

Lancet Oncol, 2021 May 14

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.

Neuro-oncology, 2020 Dec 18

A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).

Glioblastoma

Questions discussed in this category

Papers discussed in this category

Related Topics